Compare WB & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WB | SPRC |
|---|---|---|
| Founded | 2009 | 2004 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 3.3M |
| IPO Year | 2014 | 2014 |
| Metric | WB | SPRC |
|---|---|---|
| Price | $6.46 | $4.61 |
| Analyst Decision | Buy | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $8.24 | N/A |
| AVG Volume (30 Days) | ★ 883.9K | 17.9K |
| Earning Date | 11-17-2026 | 11-20-2026 |
| Dividend Yield | ★ 9.44% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.11 | $7,708.85 |
| Revenue Next Year | $0.78 | $73.22 |
| P/E Ratio | $5.66 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.37 | $0.46 |
| 52 Week High | $12.77 | $15.79 |
| Indicator | WB | SPRC |
|---|---|---|
| Relative Strength Index (RSI) | 32.11 | 39.90 |
| Support Level | N/A | $4.31 |
| Resistance Level | $6.79 | $6.24 |
| Average True Range (ATR) | 0.10 | 0.38 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 25.00 | 27.27 |
Weibo Corp is a China-based company that operates a social media platform for people to create, discover and distribute content. The company currently operates and manages its business in two principal business lines globally - advertising and marketing services and value-added services. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The company's main product is the social platform Weibo. It generates a substantial majority of its revenues from online advertising and marketing services.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.